Aurlumyn Becomes First Severe Frostbite Medication to Receive FDA Approval
Treatment aims to reduce the risk of finger or toe amputation due to frostbite.
October 24, 2026
Treatment aims to reduce the risk of finger or toe amputation due to frostbite.